REV7: a small but mighty regulator of genome maintenance and cancer development
REV7, also known as MAD2B, MAD2L2, and FANCV, is a HORMA-domain family protein crucial to multiple genome stability pathways. REV7’s canonical role is as a member of polymerase ζ, a specialized translesion synthesis polymerase essential for DNA damage tolerance. REV7 also ensures accurate cell cycle...
Saved in:
Main Authors: | Lara R. Maggs, Mitch McVey |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1516165/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the humoral immune responses of brucellosis vaccine (Rev.1) in sheep: A study from Iran
by: J. Gharekhani, et al.
Published: (2025-03-01) -
Three-dimensional reconstruction and connectivity analysis of REV-size organic matter in shales
by: Dongchen Liu, et al.
Published: (2025-01-01) -
Impact of glycolysis enzymes and metabolites in regulating DNA damage repair in tumorigenesis and therapy
by: Fengyao Sun, et al.
Published: (2025-01-01) -
Editorial: Epigenetics and genomic causality in development and chromatin research
by: Ellen V. Rothenberg, et al.
Published: (2025-02-01) -
Sir2 and Fun30 regulate ribosomal DNA replication timing via MCM helicase positioning and nucleosome occupancy
by: Carmina Lichauco, et al.
Published: (2025-01-01)